NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/11/2025
Voltar para busca
Dado oficial do USPTO
SYNEOS HEALTH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
11/11/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
35, 41, 42, 44
Data de depósito
12/12/2017
Data de registro
23/07/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/11/2025
Última transação
11/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
04/01/2018
Primeiro uso no comércio
04/01/2018
Código do desenho
3
Tipo de titular
16
Localização do titular
MORRISVILLE, CO
Examinador
SINGLETON, RUDY
Localização atual
Historical data usage
Descrição da marca
The mark consists of the term "Syneos" with the term "Health" below 'Syneos". A broken infinity symbol is in a slanted position above the letter "s" in "Syneos".
Titulares e representantes
Titulares
SYNEOS HEALTH, LLC
SYNEOS HEALTH, LLC
INC Research, LLC
Representantes
Michael A. Geller DLA PiperLLP (US)
Classificação técnica
Classes Nice
Classe 35Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Strategic business consultingmarketing and advertisingpublic relations communications strategyinformation and data collection for business purposesbusiness data analyticsanalyzing business data to understand and evaluate business performanceall of the aforementioned in the pharmaceuticalbiotechnology and life sciences fields; sales promotion services; market analysis and research services; personnel recruitment and placement; recruitment servicesadvertising clinical trialsrecruiting patientsplacing patients for participation in clinical trials for testing of pharmaceuticals and devices; consulting in sales techniques and sales programs; sales volume tracking for othersall in the pharmaceuticalbiotechnology and life sciences fields; business consulting in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalpharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; assisting pharmaceutical and biotechnology companies with applications for new drugs with governmental regulatory bodies; promoting the exchange of health information to promote patient adherence
Classe 41
Education in the field of pharmaceutical salesproviding webinarsproviding live workshopsproviding on-line non-downloadable videosproviding on-line non-downloadable publications in the nature of articles and white papersproviding podcasts; training services in the field of pharmaceutical sales; providing on-line non-downloadable newsletters and bulletins in the pharmaceuticalbiotechnology and life sciences fields; educational services in the field of clinical trialsproviding on-line non-downloadable videoswebinarslive workshopsproviding online non-downloadable publications in the nature of articles and white papersproviding podcasts
Classe 42
Medicalscientific and data analysis research services for othersconducting and analyzing clinical trials in the pharmaceuticalbiotechnology and life sciences fields; pharmaceutical drug development servicesdeveloping clinical trial methodologies; consulting services in the area of pharmaceutical clinical testing; extended clinical research services for otherscomputerized data management of clinical trialsbiostatistical analysisenvironmental consultancypreclinical research and development evaluationrepairing flawed clinical trials and dossiersstrategic clinical research portfolio managementbiosurveillance monitoring; providing life science and scientific research information to physicians and other health care professionalspatientsmedicalpharmaceutical and biotechnology companies; providing regulatory compliant technical writing services in the field of medical research and clinical studies; consulting services in the field of contract clinical research and contract product development; Internet developmentdesign and consulting services for otherscreating websites featuring blogs about medical and pharmaceutical information related to chronic illnesses and diseasecreating an online community for patients and caregivers to communicate about healthcaredesign and development of interactive software for use in the communication and dissemination of medical and pharmaceutical information
Classe 44
Providing medical information to physiciansother health care professionals and for medical patients; providing health information regarding the medications and health care products of othersproduct discontinuationsnew formulationsbottle changesseasonal information through e-mail alerts and push notifications
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/11/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/11/2025
E815
TEAS SECTION 8 & 15 RECEIVED
21/07/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
23/07/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/10/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
15/03/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
23/07/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
15/06/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
14/06/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
18/05/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
18/05/2019
IUAF
USE AMENDMENT FILED
06/05/2019
EISU
TEAS STATEMENT OF USE RECEIVED
06/05/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
24/04/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/04/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/04/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/03/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/01/2019
PUBO
PUBLISHED FOR OPPOSITION
08/01/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/12/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/11/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/10/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/10/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/10/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/07/2018
GNRT
NON-FINAL ACTION E-MAILED
05/07/2018
CNRT
NON-FINAL ACTION WRITTEN
05/07/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/06/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/06/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/06/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
30/03/2018
GNRT
NON-FINAL ACTION E-MAILED
30/03/2018
CNRT
NON-FINAL ACTION WRITTEN
30/03/2018
DOCK
ASSIGNED TO EXAMINER
22/03/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
22/12/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/12/2017
NWAP
NEW APPLICATION ENTERED
15/12/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SYNEOS HEALTH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.